AlphAIAlphAI — Financial news for AI agents
gurufocus.comOCT 203 min read$ISRG

How Did Intuitive Surgical Inc (ISRG) Perform in Q3? EPS of $1.4

Intuitive Surgical (ISRG) reported Q3 2026 revenue of $3.05B, up 22% YoY, but GAAP net income fell to $523M ($1.49/diluted share) due to a $450M legal charge. Procedures grew 15% YoY, with systems and instruments revenue up 30% and 18%, respectively. The company's installed base increased 12% for da Vinci and 21% for Ion systems. GuruFocus values ISRG at $635.52, suggesting a 31.1% undervaluation.

Original reporting
gurufocus.com
Published Oct 20, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 10:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$ISRG
Bearish
high confidence
Mentioned
$ISRG
Relevance
8/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$ISRGBearishHigh
01

Why it matters

The earnings mix of strong top‑line growth and a sizable legal charge creates a mixed outlook for the stock.

02

Market read

First‑hand earnings data for a large‑cap medical‑device company; material for short‑term traders.

03

What to watch

Potential upside from expanding Ion platform adoption and 12% growth in installed base.

Relevance 8/10Novelty 8/10Timing: after‑hours release on Oct 20, 2026

Background

Intuitive Surgical disclosed its Q3 2026 results via an 8‑K filing, including a $450M pre‑tax legal settlement.

Company-level read

Ticker impact

$ISRGBearishHigh confidence
Context

Q3 2026 earnings report shows revenue $3.05B beating estimates but EPS $1.49 down YoY due to a $450M legal settlement charge.

Expected impact

likely downward pressure as investors price in the large legal charge despite revenue beat

Evidence & confidence

The legal settlement significantly reduces net income, outweighing the revenue beat and could trigger sell‑offs.

Market effects

Sector

Highlights risk of litigation exposure for medical‑device makers, may prompt sector‑wide scrutiny.

Regional

U.S. healthcare equipment sector could see modest pullback.

Global

Limited to investors with exposure to Intuitive Surgical and comparable robotic surgery firms.

Counterpoint

What could challenge this read

Revenue beat and strong system adoption could support a rebound if the settlement is viewed as a one‑off.

Key entities

  • company
    Intuitive Surgical Inc

    Leader in robotic‑assisted minimally invasive surgery.

Read at source← All news

StoryIntuitive Surgical posts Q3 2026 results with revenue up 22% and a $450 million antitrust settlement charge

Also covered by

4 outlets

Related articles

OCT 20
$ISRGMedAI 8/10

Intuitive Surgical, Inc (ISRG) Q3 2026 Earnings Call Transcript

Intuitive Surgical (ISRG) reported Q3 2026 earnings, highlighting 15% total procedure growth, with 14% in da Vinci and 31% in Ion procedures. U.S. da Vinci growth was 10%, while international growth was 20%. The company installed over 13,200 da Vinci and Ion systems worldwide. Revenue growth was driven by strong demand for da Vinci 5 and SP platforms, with 28% increase in system placements. The company also announced plans for a new manufacturing facility in Malaysia.

news.alphastreet.com3 min
OCT 20
$ISRGMedAI 8/10

Intuitive Surgical (ISRG) Q3 Earnings Beat Expectations with Str

Intuitive Surgical (ISRG) reported Q3 earnings that surpassed expectations, with revenue of $3.05B, up 21.5% YoY, and EPS of $3.00. The company saw a 15% rise in procedures and placed 546 new da Vinci systems. ISRG's GF Value suggests it is undervalued by 31.1%, with a GF Score of 96/100. Insiders sold $93.4M in shares, while gurus show mixed activity.

gurufocus.com2 min